CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The round ...
A campaign active since last November has been targeting Python developers building Telegram bots with trojanized Pyrogram ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results